Opinion leaders in each of four countries in the Central European region summarize the available data on hepatitis C virus (HCV) epidemiology. The overall prevalence of anti-HCV antibody reactivity in this region varies between 0.2% and 2.1%, the most prevalent HCV genotype is GT 1. The commonest route of transmission is intravenous drug abuse at present.

Central Outpatient Clinic Saint Laszlo Hospital Budapest Hungary

Department of Infectious Diseases Medical University of Lublin Lublin Poland

Department of Infectology and Travel Medicine Faculty of Medicine University of P J Safarik Kosice Slovak Republic

Department of Internal Medicine 1 Medical Faculty Charles University and Central Military Hospital Prague Czech Republic

United Saint Istvan and Saint Laszlo Hospital Saint Laszlo Hospital Outpatient Clinic Budapest Hungary

Zobrazit více v PubMed

Němeček V. Sérologický přehled ČR v roce 2001 – virová hepatitida A, B, C. Zprávy CEM. 2003;12:55–61. příloha 1. [Article in Czech]

Husa P, Husova L. Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons. Bratisl Lek Listy. 2001;102:248–252. PubMed

Urbánek P, Husa P, Šperl J, et al. Standardní diagnostický a terapeutický postup chronické infekce virem hepatitidy C. Gastroent Hepatol. 2015;69:455–471. [Article in Czech]

Schréter I, Kristian P, Klement C, et al. Prevalence of hepatitis C virus infection in Slovakia. Klin Mikrobiol Infekc Lek. 2007;13:54–58. [Article in Slovak] PubMed

Kristian P, Schréter I, et al. EPID study, data on file

Paraličová Z, Kristian P, Schréter I. Epidemiological survey of hepatitis C at the Clinic of Infectology and Travel Medicine in Kosice. Epidemiol Mikrobiol Imunol. 2009;58:158–162. [Article in Slovak] PubMed

Hatzakis A, Chulanov V, Gadano AC, et al. The present and future disease burden of hepatitis C virus (HCV) infections with today’s treatment paradigm – volume 2. J Viral Hepat. 2015;22(Suppl 1):26–45. PubMed

Muller Z, Deak J, Horanyi M, et al. The detection of hepatitis C virus in South Hungary. J Clin Virol. 2001;20:81–83. PubMed

Barna TK, Ozsvar Z, Szendrenyi V, et al. Hepatitis C virus antibody in the serum of blood donors. Orv Hetil. 1996;137:507–511. PubMed

Merkinaite S. Siauliu St. 5/1-21, Vilnius 01133, Lithuania: Eurasian Harm Reduction Network (EHRN), formerly Central and Eastern European Harm Reduction Network (CEEHRN) 2007. Oct 1, HCV infection in Europe.

European Monitoring Centre for Drugs and Drug Addiction. Selected Issues/European Monitoring Centre for Drugs and Drug Addicton. European Monitoring Centre for Drugs and Drug Addiction; 2010. EMCDDA 2010 Selected Issue-Trends in Injecting Drug use in Europe European Union. Annual Report; p. 22.

Mihaly I, Telegdy L, Ibranyi E, et al. Prevalence, genotype distribution and outcome of hepatitis C infections among the employees of the Hungarian Central Hospital for infectious diseases. J Hosp Infect. 2001;49:239–244. PubMed

McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994;32:884–892. PubMed PMC

Tresó B, Takács M, Dencs Á, et al. Molecular epidemiology of hepatitis C virus genotypes and subtypes among injecting drug users in Hungary. Euro Surveill. 2013;18:20639. doi: http://dx.doi.org/10.2807/1560-7917.ES2013.18.47.20639. PubMed DOI

Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe – a review. Euro Surveill. 2008;13:1–8. PubMed

Flisiak R, Halota W, Horban A, et al. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol. 2011;23:1213–1217. PubMed

Godzik P, Kolakowska A, Madalinski K, et al. Prevalence of anti-HCV antibodies among adults in Poland – results of cross-sectional study in general population. Przegl Epidemiol. 2012;66:575–580. [Article in Polish] PubMed

Panasiuk A, Flisiak R, Mozer-Lisewska I, et al. Distribution of HCV genotypes in Poland. Przeg Epidemiol (Epidemiol Rev) 2013;67:11–16. [Article in English, Polish] PubMed

Flisiak R, Halota W, Tomasiewicz K, et al. Forecasting the disease burden of chronic hepatitis C virus in Poland. Eur J Gastroenterol Hepatol. 2015;27:70–76. PubMed